TGTX Stock Outperforms 95% of Stocks. Here’s Why.

Multiple sclerosis treatment biotech stock TG Therapeutics (TGTX) is Monday’s IBD 50 Growth Stocks To Watch selection. The stock is clawing back from a sharp drop earlier this month, and Wall Street is expecting to see explosive earnings growth in upcoming quarters. TG Therapeutics holds the No. 4 spot in the IBD 50 behind Travere Therapeutics (TVTX), Eton Pharmaceuticals (ETON) and…